NUWE RSI Chart
Last 7 days
4%
Last 30 days
-7.1%
Last 90 days
-56.7%
Trailing 12 Months
-91.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 8.9M | 0 | 0 | 0 |
2023 | 8.4M | 8.3M | 8.7M | 8.9M |
2022 | 7.9M | 7.6M | 7.8M | 8.5M |
2021 | 7.7M | 8.4M | 8.3M | 7.9M |
2020 | 5.9M | 6.1M | 6.8M | 7.4M |
2019 | 5.2M | 5.8M | 5.6M | 5.5M |
2018 | 3.7M | 3.9M | 4.3M | 5.0M |
2017 | 2.2M | 3.1M | 3.5M | 3.6M |
2016 | 0 | 0 | 543.0K | 1.3M |
2015 | 295.0K | 295.0K | 236.0K | 59.0K |
2014 | 118.0K | 177.0K | 236.0K | 295.0K |
2013 | 0 | 0 | 233.0K | 59.0K |
2010 | 0 | 0 | 0 | 407.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 15, 2023 | jaramillo nestor jr. | bought | 19,629 | 4.79 | 4,098 | president and ceo |
Which funds bought or sold NUWE recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 24.83 | -183 | 598 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | new | - | 9,258 | 9,258 | -% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | reduced | -45.39 | -8,390 | 4,211 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | added | 492 | 29,857 | 41,063 | -% |
May 14, 2024 | Qube Research & Technologies Ltd | unchanged | - | -2.00 | 3.00 | -% |
May 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | unchanged | - | -2,461 | 3,989 | -% |
May 13, 2024 | FMR LLC | added | 300 | - | 1.00 | -% |
May 13, 2024 | UBS Group AG | new | - | 168 | 168 | -% |
May 13, 2024 | HRT FINANCIAL LP | new | - | 4,000 | 4,000 | -% |
May 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | sold off | -100 | -32,000 | - | -% |
Unveiling Nuwellis, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Nuwellis, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Nuwellis, Inc. News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -27.2% | 1,857,000 | 2,551,000 | 2,412,000 | 2,075,000 | 1,826,000 | 2,339,000 | 2,065,000 | 2,213,000 | 1,926,000 | 1,642,000 | 1,853,000 | 2,508,000 | 1,918,000 | 2,044,000 | 1,904,000 | 1,863,000 | 1,630,000 | 1,367,000 | 1,252,000 | 1,677,000 | 1,215,000 |
Gross Profit | -14.2% | 1,191,000 | 1,388,000 | 1,381,000 | 1,147,000 | 1,067,000 | 1,331,000 | 1,259,000 | 1,063,000 | 1,102,000 | 894,000 | 1,120,000 | 1,511,000 | 966,000 | 1,146,000 | 878,000 | 1,199,000 | 834,000 | - | - | - | - |
Costs and Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6,328,500 | 6,161,000 | 5,783,000 | 6,197,000 | 5,813,000 | 5,759,000 | 6,105,000 | 5,940,000 |
Operating Expenses | 19.3% | 5,940,000 | 4,981,000 | 4,545,000 | 6,169,000 | 6,918,000 | 5,865,000 | 5,179,000 | 5,364,000 | 5,518,000 | 5,225,000 | 6,371,000 | 6,237,000 | 6,184,000 | 5,430,500 | 5,135,000 | 5,119,000 | 5,401,000 | - | - | - | - |
S&GA Expenses | 27.6% | 4,606,000 | 3,609,000 | 3,428,000 | 4,664,000 | 5,490,000 | 4,664,000 | 4,251,000 | 4,257,000 | 4,412,000 | 4,094,000 | 4,645,000 | 5,063,000 | 5,237,000 | 4,382,500 | 4,264,000 | 4,234,000 | 4,537,000 | 4,187,000 | 4,107,000 | 3,973,000 | 4,018,000 |
R&D Expenses | -2.8% | 1,334,000 | 1,372,000 | 1,117,000 | 1,505,000 | 1,428,000 | 1,201,000 | 928,000 | 1,107,000 | 1,106,000 | 1,131,000 | 1,726,000 | 1,174,000 | 947,000 | 1,048,000 | 871,000 | 885,000 | 864,000 | 953,000 | 1,112,000 | 1,297,000 | 1,310,000 |
EBITDA Margin | 11.1% | -1.99 | -2.24 | -1.88 | -2.02 | -1.92 | -1.66 | -2.11 | -2.35 | -2.31 | -2.41 | -2.14 | -2.01 | - | - | - | - | - | - | - | - | - |
Income Taxes | 0% | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 3,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 3,000 | 2,000 | 2,000 | 3,000 | 2,000 | 2,000 | 3,000 | 1,000 | 2,000 | 2,000 |
Earnings Before Taxes | 21.4% | -4,328,000 | -5,507,000 | -3,368,000 | -4,843,000 | -6,483,000 | -1,893,000 | -3,868,000 | -4,284,000 | -4,471,000 | -4,328,000 | -5,270,000 | -4,728,000 | -5,219,000 | -3,084,000 | -4,257,000 | -3,920,000 | -4,566,000 | -4,445,000 | -4,508,000 | -4,428,000 | -4,725,000 |
EBT Margin | 11.0% | -2.03 | -2.28 | -1.92 | -2.06 | -1.96 | -1.70 | -2.16 | -2.40 | -2.37 | -2.47 | -2.20 | -2.06 | - | - | - | - | - | - | - | - | - |
Net Income | 31.2% | -3,789,000 | -5,509,000 | -3,370,000 | -4,845,000 | -6,485,000 | -1,896,000 | -3,870,000 | -4,286,000 | -4,473,000 | -4,330,000 | -5,272,000 | -4,731,000 | -5,221,000 | -3,086,000 | -4,260,000 | -3,922,000 | -4,568,000 | -4,448,000 | -4,509,000 | -4,430,000 | -4,727,000 |
Net Income Margin | 13.6% | -1.97 | -2.28 | -1.92 | -2.06 | -1.96 | -1.70 | -2.16 | -2.41 | -2.37 | -2.47 | -2.20 | -2.07 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -6.4% | -2,891,000 | -2,718,000 | -3,946,000 | -5,303,000 | -6,119,000 | -3,146,000 | -3,279,000 | -3,949,000 | -4,897,000 | -4,183,000 | -4,540,000 | -3,901,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -31.8% | 6,662 | 9,770 | 11,432 | 15,553 | 18,479 | 24,673 | 18,437 | 21,998 | 26,107 | 30,417 | 34,095 | 29,640 | 33,563 | 20,012 | 23,719 | 13,143 | 10,047 | 5,602 | 7,584 | 11,428 | 15,363 |
Current Assets | -36.7% | 5,197 | 8,209 | 9,638 | 13,748 | 16,610 | 22,769 | 16,440 | 19,920 | 23,895 | 28,126 | 32,725 | 28,224 | 32,138 | 18,536 | 22,151 | 11,729 | 8,732 | 4,036 | 6,051 | 10,302 | 14,251 |
Cash Equivalents | -63.2% | 1,400 | 3,800 | 4,930 | 8,896 | 11,515 | 17,737 | 12,053 | 15,345 | 19,300 | 8,742 | 28,431 | 23,978 | 27,893 | 14,437 | 17,947 | 7,821 | 5,669 | 1,279 | 3,634 | 7,402 | 11,489 |
Inventory | 6.7% | 2,131 | 1,997 | 2,336 | 2,733 | 2,742 | 2,661 | 2,919 | 3,010 | 3,294 | 2,843 | 2,805 | 2,656 | 2,957 | 2,957 | 2,921 | 2,789 | 2,195 | 1,797 | 1,612 | 1,690 | 1,790 |
Net PPE | -6.5% | 681 | 728 | 912 | 875 | 907 | 980 | 1,027 | 1,063 | 1,153 | 1,188 | 1,265 | 1,260 | 1,219 | 1,200 | 1,244 | 1,042 | 897 | 991 | 1,025 | 574 | 518 |
Liabilities | -12.0% | 5,775 | 6,559 | 3,593 | 4,479 | 4,815 | 12,316 | 4,421 | 4,334 | 4,394 | 4,470 | 4,114 | 3,644 | 3,211 | 3,694 | 3,391 | 3,541 | 2,343 | 3,612 | 3,246 | 2,994 | 2,835 |
Current Liabilities | 36.3% | 4,323 | 3,172 | 2,992 | 3,825 | 4,107 | 4,688 | 3,611 | 3,459 | 3,392 | 3,307 | 3,795 | 3,603 | 3,163 | 3,585 | 3,223 | 3,335 | 2,131 | 3,351 | 2,937 | 2,637 | 2,432 |
Shareholder's Equity | -70.4% | 885 | 2,990 | 7,839 | 11,074 | 13,664 | 12,357 | 14,016 | 17,664 | 21,713 | 25,947 | 29,981 | 25,996 | 30,352 | 16,318 | 20,328 | 9,602 | 7,704 | 1,990 | 4,338 | 8,434 | 12,528 |
Retained Earnings | -1.5% | -291,956 | -287,600 | -282,100 | -278,747 | -273,900 | -267,417 | -265,545 | -261,700 | -257,389 | -252,892 | -257,400 | -243,300 | -238,559 | -233,338 | -230,252 | -225,992 | -222,070 | -217,502 | -213,054 | -208,545 | -204,115 |
Additional Paid-In Capital | 0.8% | 292,880 | 290,646 | 289,980 | 289,845 | 287,529 | 279,736 | 279,570 | 279,350 | 279,114 | 278,874 | 278,552 | 269,296 | 268,921 | 249,663 | 249,378 | 234,381 | 228,560 | 218,278 | 216,173 | 215,761 | 215,422 |
Shares Outstanding | 19.7% | 6,801 | 5,682 | 1,864 | 1,864 | 1,207 | 536 | 105 | 105 | 105 | 105 | 56.00 | 49.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 5,000 | - | - | - | 6,200 | - | - | - | 27,400 | - | - | - | 8,300 | - | - | - | 8,300 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -3.9% | -2,862 | -2,754 | -3,825 | -5,252 | -6,106 | -3,127 | -3,257 | -3,938 | -4,827 | -4,155 | -4,486 | -3,820 | -5,382 | -3,409 | -4,403 | -3,265 | -5,495 | -4,030 | -3,463 | -3,967 | -4,907 |
Share Based Compensation | 0.6% | 158 | 157 | 135 | 197 | 181 | 165 | 220 | 236 | 241 | 321 | 257 | 381 | 355 | 313 | 309 | 347 | 380 | 399 | 412 | 339 | 362 |
Cashflow From Investing | -180.6% | -29.00 | 36.00 | -121 | 513 | -98.00 | 14,831 | -22.00 | -11.00 | -70.00 | -15,528 | -54.00 | -81.00 | -56.00 | -60.00 | -138 | -52.00 | -17.00 | -26.00 | -306 | -117 | -41.00 |
Cashflow From Financing | -68.7% | 500 | 1,595 | -20.00 | 2,119 | -11.00 | 9,451 | -15.00 | -7.00 | -6.00 | -5.00 | 8,993 | -14.00 | 18,897 | -34.00 | 14,674 | 5,471 | 9,905 | 1,706 | - | - | 10,959 |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Condensed Consolidated Statements of Operations and Comprehensive Loss [Abstract] | ||
Net sales | $ 1,857 | $ 1,826 |
Cost of goods sold | 666 | 759 |
Gross profit | 1,191 | 1,067 |
Operating expenses: | ||
Selling, general and administrative | 4,606 | 5,490 |
Research and development | 1,334 | 1,428 |
Total operating expenses | 5,940 | 6,918 |
Loss from operations | (4,749) | (5,851) |
Other income (expense), net | (101) | 123 |
Change in fair value of warrant liability | 522 | (755) |
Loss before income taxes | (4,328) | (6,483) |
Income tax expense | (2) | (2) |
Net loss | (4,330) | (6,485) |
Deemed dividend attributable to Series J Convertible Preferred Stock | 541 | 0 |
Net loss attributable to common stockholders | $ (3,789) | $ (6,485) |
Basic loss per share (in dollars per share) | $ (0.6) | $ (5.76) |
Diluted loss per share (in dollars per share) | $ (0.6) | $ (5.76) |
Weighted average shares outstanding - basic (in shares) | 6,286,298 | 1,125,993 |
Weighted average shares outstanding - diluted (in shares) | 6,286,298 | 1,125,993 |
Other comprehensive loss: | ||
Net loss | $ (4,330) | $ (6,485) |
Unrealized gain on marketable securities | 0 | 6 |
Foreign currency translation adjustments | (9) | (7) |
Total comprehensive loss | $ (4,339) | $ (6,486) |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 1,400 | $ 3,800 |
Accounts receivable | 1,226 | 1,951 |
Inventories, net | 2,131 | 1,997 |
Other current assets | 440 | 461 |
Total current assets | 5,197 | 8,209 |
Property, plant and equipment, net | 681 | 728 |
Operating lease right-of-use asset | 664 | 713 |
Other assets | 120 | 120 |
TOTAL ASSETS | 6,662 | 9,770 |
Current liabilities | ||
Accounts payable and accrued liabilities | 3,332 | 2,380 |
Accrued compensation | 725 | 525 |
Current portion of operating lease liability | 221 | 216 |
Other current liabilities | 45 | 51 |
Total current liabilities | 4,323 | 3,172 |
Common stock warrant liability | 964 | 2,843 |
Operating lease liability | 488 | 544 |
Total liabilities | 5,775 | 6,559 |
Commitments and contingencies | ||
Mezzanine Equity | ||
Series J Convertible Preferred Stock as of March 31, 2024 and December 31, 2023, par value $0.0001 per share; authorized 600,000 shares, issued and outstanding 82 and 11,950, respectively | 2 | 221 |
Stockholders' equity | ||
Preferred stock | 0 | 0 |
Common stock as of March 31, 2024 and December 31, 2023, par value $0.0001 per share; authorized 100,000,000 shares, issued and outstanding 6,801,443 and 5,682,461, respectively | 1 | 1 |
Additional paid-in capital | 292,880 | 290,646 |
Accumulated other comprehensive income: | ||
Foreign currency translation adjustment | (40) | (31) |
Accumulated deficit | (291,956) | (287,626) |
Total stockholders' equity | 885 | 2,990 |
TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY | 6,662 | 9,770 |
Series A Junior Participating Preferred Stock [Member] | ||
Stockholders' equity | ||
Preferred stock | 0 | 0 |
Series F Convertible Preferred Stock [Member] | ||
Stockholders' equity | ||
Preferred stock | $ 0 | $ 0 |